| 1 |
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis [ J] . Circulation, 2002; 105: 1135 -43
|
| 2 |
Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methyl- glutaryl coenzyme a reductase inhibitors[ J] . Arterioscler Thromb Vasc Biol, 2001; 21 : 1712-9
|
| 3 |
Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A. Non-lipid- related effects of statins[ J] . Ann Med, 2000 ; 32: 164-76
|
| 4 |
Shah PK, Falk E, Badimon JJ .Human monocyte-derived mac- rophages induce collagen breakdown in fibrous caps of athero- sclerotic plaques . Potential role of matrix-degrading metallopro- teinases and implications for plaque rupture [ J] .Circulation, 1999 ; 92: 1565-9
|
| 5 |
Tziakas DN, Chalikias GK, Parissis JT, Hatzinikolaou EI, Pap- adopoulos ED, Tripsiannis GA, et al .Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes, The effects of short-term atorvastatin admin- istration[ J] . Int J Cardiol, 2004; 94 : 269-77
|
| 6 |
Hwang YS, Tsai WC, Lu YH, Lin CC, Chen YF.Effect of Atorv- astatin on the expression of CD40 ligand and p-selectin on plate- lets in patients with hypercholesterolemia[ J] .Am J Cardiol, 2004 ; 94: 364 -6
|
| 7 |
沈敏, 李兰荪.阿托伐他汀对不稳定型心绞痛患者 C 反应 蛋白及细胞粘附分子的影响[ J] .临床内科杂志, 2003; 20: 74-6
|
| 8 |
许竹梅, 赵水平, 聂赛, 周宏年, 李全忠, 刘玲.阿托伐他汀 增加单核细胞过氧化物酶增殖体激活受体γ表达改善炎 症反应[ J] .中华心血管病杂志, 2004; 32 : 329-33
|
| 9 |
Burleigh ME, Babaev VR, OatesJA, Harris RC,Gautam S, Rien- deau D, et al .Cy clooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-2 deficient mice[ J] .Circula- tion, 2002; 105 : 1816-23
|
| 10 |
赵水平, 邓平, 吴洁, 周宏年, 聂赛.阿托伐他汀短期治疗 对急性冠状动脉综合征外周血单核细胞环氧化酶 2 信使 核糖核酸表达的影响[ J] .中国循环杂志, 2005; 20 : 165-8
|
| 11 |
Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, Princen HM, et al . Effect of low dose atorvastatin versus diet-in- duced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein e ＊3-leiden transgenic mice [ J] . Arterioscler Thromb, 2005; 25 : 161-7
|
| 12 |
Pasceri V, Wu HD, Willerson JT, Yeh ET.Modulation of vascu- lar inflammation in vivo and in vitro by peroxisome prolifera- tors2activator2γ activators[ J] . Circulation, 2000; 101 : 235-8
|
| 13 |
赵水平, 张大庆, 周宏年, 聂赛, 李全忠.阿托伐他汀对脂 肪细胞分泌白细胞介素 6 的影响[ J] .中华内科杂志, 2003 ; 42: 874 -5
|
| 14 |
Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, et al . Pravastatin and the development of diabetes mellitus:evi- dence of a protective treatment effect in the west of scotland cor- onary prevention study[ J] . Circulation, 2001; 103 : 357 -62
|
| 15 |
Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabol- ic factors, inflammatory markers, and vascular reactivity in dia- betic patients and subjects at risk for diabetes[ J] .Diabetes Care, 2004; 27: 2450 -7
|
| 16 |
Atalar E, Ozmen F, Haznedaroglu I, Acil T, Ozer N, Ovunc K, et al .Effects of short-term atorvastatin treatment on global fibrino- lytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease[ J] .Int J Cardiol, 2002; 84: 227-31
|
| 17 |
李洁琪, 赵水平, 方颖, 吴立荣, 李屏.阿托伐他汀对培养 的兔脂肪细胞凝血和纤溶因子的影响及其机制[ J] .中国 循环杂志, 2005; 20 : 221-4
|
| 18 |
袁晓华, 张蕴.超常规量阿托伐他汀对急性心肌梗死患 中国临床药理学与治疗学 2006 Feb; 11( 2) · 143 ·者早期血管内皮功能的影响[ J] .天津医科大学学报, 2004; 10 : 170-2
|
| 19 |
范伯丽, 程颖, 房家智, 蒋宝琦, G Neil Thomas, Julian AJH Critchley, 等.阿托伐他汀对高脂血症患者血小板聚集反 应的影响[ J] .中国动脉硬化杂志, 2003; 11: 455 -8
|
| 20 |
Li DY, Chen HJ,Mehta JL. Statins inhibit oxidized-LDL-mediat- ed LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation[ J] . Cardiovasc Res, 2001; 52 : 130-5
|
| 21 |
Zhao SP, Zhang DQ.Atorvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits [ J] . Clinica Chimica Acta, 2004 ; 339 : 189-94
|
| 22 |
Fuhrman B, Koren L, Volkova N, Keidar S, Hayek T, Aviram M.Atorvastatin therapy in hypercholesterolemic patients sup- presses cellular uptake of oxidized-LDL by differentiating mono- cytes[ J] . Atherosclerosis, 2002; 164 : 179-85
|
| 23 |
Giuseppe M, Sandra Z, Francesca S.Effect of Atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels[ J] . Am J Cardiol, 2002 ;
|
| 90 |
: 747 -50
|
| 24 |
陈斌, 邓玉莲, 吴志勇, 高美钦, 郑伟, 黄爱民.阿托伐他 汀对兔动脉粥样硬化模型血管壁平滑肌细胞凋亡的影响 [ J] .中国老年学杂志, 2004; 24: 542 -4
|
| 25 |
Carlos G, Luis M, Blanco C,Monica O. 3-hydroxy-3- methylglu- taryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth musclecells in culture [ J] .Circ Res, 1998; 83: 490 -500
|
| 26 |
Harvey S, Hecht S, Mitchell H .Comparison of the effects of atorvastatin versus simvastatin on subclinical atherosclerosis in primary prevention as determined by electron beam tomography [ J] . Am J Cardiol, 2003; 91: 42 -5
|
| 27 |
Sweder WE, Dianne JM .Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque de- velopment in APOE＊3 Leiden transgenic mice[ J] . Atheroscle- rosis, 2002 ; 164: 65-71
|
| 28 |
Newman CB, Palmer G, Silbershatz H, Szarek M. Safety of atorv- astatin derived from analysis of 44 completed trials in 9, 416 pa- tients[ J] . Am J Cardiol, 2003 ; 92: 670-6
|
| 29 |
陈雯艾, 陈君柱, 胡晓晟, 朱建华, 冯立民, 姚雪艳.阿托 伐他汀治疗原发性高脂血症的疗效和安全性[ J] .中华心 血管病杂志, 2003; 31 : 577
|
| 30 |
Terry AJ .Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome p450 inhibitors[ J] .Am J Cardiol, 2004;94: 1140 -6
|
